CoChat

Characterization of the Specific Interaction between Sialoadhesin and Sialylated Campylobacter jejuni Lipooligosaccharides

Open access
Heikema, Astrid P., Bergman, Mathijs P., Richards, Hannah, Crocker, Paul R., Gilbert, Michel, Samsom, Janneke N., van Wamel, Willem J. B., Endtz, Hubert P., van Belkum, Alex · 2010 · Infection and Immunity

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

In Campylobacter jejuni -induced Guillain-Barré syndrome (GBS), molecular mimicry between C. jejuni lipooligosaccharide (LOS) and host gangliosides leads to the production of cross-reactive antibodies directed against the peripheral nerves of the host. Currently, the presence of surface exposed sialylated LOS in C. jejuni is the single known bacterial pathogenesis factor associated with the development of GBS. Using a unique, well-characterized strain collection, we demonstrate that GBS-associated C. jejuni strains bind preferentially to sialoadhesin (Sn, Siglec-1, or CD169), a sialic acid receptor found on a subset of macrophages. In addition, using a whole-cell enzyme-linked immunosorbent assay (ELISA), C. jejuni strains with sialylated LOS bound exclusively to soluble Sn. Mass spectrometry revealed that binding was sialic acid-linkage specific with a preference for α(2,3)-linked sialic acid attached to the terminal galactose of the LOS chain as seen in the gangliosides GD1a, GM1b, and GM3. This molecular interaction was also related to functional consequences as a GBS-associated C. jejuni strain that bound Sn in a whole-cell ELISA adhered to surface-expressed Sn of Sn-transfected CHO cells but was unable to adhere to wild-type CHO cells. Moreover, a sialic acid-negative mutant of the same C. jejuni strain was unable to bind Sn-transfected CHO cells. This is the first report of the preferential binding of GBS-associated C. jejuni strains to the Sn immune receptor ( P = 0.014). Moreover, because this binding is dependent on sialylated LOS, the main pathogenic factor in GBS progression, the present findings bring us closer to unraveling the mechanisms that lead to formation of cross-reactive antibodies in GBS disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/iai.01273-09

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

See all 103

Metadata

Authors
Heikema, A. P., Bergman, M. P., Richards, H., Crocker, P. R., Gilbert, M., Samsom, J. N., van Wamel, W. J. B., Endtz, H. P., & van Belkum, A.
Affiliations
  • Department of Medical Microbiology and Infectious Diseases
  • Vrije Universiteit Amsterdam (NL)
  • University of Dundee (GB)
  • Institute for Biological Sciences (CA)
  • Erasmus MC (NL)
  • International Centre for Diarrhoeal Disease Research (BD)
Venue
Infection and Immunity
Published
2010-07
Volume
78
Issue
7
Pages
3237-3246
ISSN
  • 0019-9567 (ISSN-L)
  • 1098-5522
OpenAlex
W2029004774
Cited by
103
References
42
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 6 · 2021: 11 · 2020: 7 · 2019: 2 · 2018: 8 · 2017: 4 · 2016: 5 · 2015: 6 · 2014: 13 · 2013: 5 · 2012: 18
FWCI
3.51
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Infection and Immunity (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • VU Research Portal (publishedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • NPARC (submittedVersion)
  • Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
Wellcome Trust (081882)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
Campylobacter jejuni, Guillain-Barré syndrome, sialoadhesin, Siglec-1, CD169, lipooligosaccharide, sialic acid, α2,3-linked sialic acid, gangliosides, molecular mimicry, cross-reactive antibodies, bacterial adhesion, macrophages, bacterial pathogenesis
MeSH terms
Animals, Campylobacter Infections, Cricetulus, Enzyme-Linked Immunosorbent Assay, Gangliosides, Cricetinae, Humans, Lipopolysaccharides, Membrane Glycoproteins, Receptors, Immunologic, Campylobacter jejuni, CHO Cells, N-Acetylneuraminic Acid, Guillain-Barre Syndrome, Sialic Acid Binding Ig-like Lectin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterization of the Specific Interaction between Sialoadhesin and Sialylated Campylobacter jejuni Lipooligosaccharides. https://app.cochat.ai/papers/10.1128/iai.01273-09
The paper
Heikema, A. P., Bergman, M. P., Richards, H., Crocker, P. R., Gilbert, M., Samsom, J. N., van Wamel, W. J. B., Endtz, H. P., & van Belkum, A. (2010). Characterization of the Specific Interaction between Sialoadhesin and Sialylated Campylobacter jejuni Lipooligosaccharides. Infection and Immunity. https://doi.org/10.1128/iai.01273-09

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.